Livzon Pharmaceuticals (01513) plans to acquire about 0.13% of Xinbeijiang Pharmaceutical's shares held by Zhonghuiyuan

Zhitongcaijing · 2d ago

According to Zhitong Finance App, Lizhu Pharmaceutical (01513) announced that on November 11, 2026, the company and Zhonghuiyuan entered into a share transfer agreement with Zhonghuiyuan. The company agreed to purchase about 0.13% of the shares of Xinbeijiang Pharmaceutical held by Zhonghuiyuan at a cash consideration of approximately RMB 3.8525 million (corresponding to the registered capital of Xinbeijiang Pharmaceutical about RMB 303,600). After the acquisition of Xinbeijiang Pharmaceutical Co., Ltd. is completed, the Company's direct interest in Xinbeijiang Pharmaceutical will increase from about 90.64% to about 90.77%.

As an employee shareholding platform for Xinbeijiang Pharmaceutical, Zhonghuiyuan plans to acquire part of Xinbeijiang Pharmaceutical's shares in order to further optimize the shareholding structure of Xinbeijiang Pharmaceutical, strengthen the company's control over core pharmaceutical subsidiaries, and improve the efficiency of management decisions. This transaction is a normal operating arrangement for the Company to optimize the governance of subsidiaries and deepen the industrial layout. It conforms to the Company's overall development strategy plan, and conforms to the long-term development interests of the Company and the overall interests of all shareholders. This transaction will not cause major changes in the current and future financial conditions and operating results of the Company, and will not adversely affect the Company's daily operations.